首页> 外文期刊>Pakistan journal of medical sciences. >Haemorheological changes in cancer patients on chemotherapy
【24h】

Haemorheological changes in cancer patients on chemotherapy

机译:癌症患者化疗后的血液流变学变化

获取原文
获取外文期刊封面目录资料

摘要

Objective: To assess the rheological changes in haematological and non-haematological cancer patients’ pre and post chemotherapy.Patients and Method: It is a prospective study of 50 patients comprising 16(32%) haematological and 34(68%) non-haematological cancers of various types from March to December 2005 at University of Benin Teaching Hospital, Nigeria. Rheologic parameters estimated by the various specific diagnostic methods were determined in cancer patient’s pre and post chemotherapy. The rheological tests estimated were relative plasma viscosity (RPV) measured by means of a capillary viscometer, whole blood viscosity (WBV), erythrocyte sedimentation rate (ESR) and plasma fibrinogen concentration (PFC) estimated by the Ingram’s Clot weight method.Results: The RPV in pre chemotherapy (p=0.006) and WBV in post chemotherapy (p=0.0231) patients measured revealed a significant difference when compared to controls. The fibrinogen concentration (P<0.0001) and ESR values (P<0.0001) were significantly increased in cancer patients when compared to controls. Conclusion: We conclude that total reduction of hyperviscosity and hyperfibrinogenaemia may contribute to effective treatment strategies in cancer patients.
机译:目的:评估化疗前后血液和非血液癌症患者的流变变化。患者与方法:前瞻性研究50例分别由16(32%)血液学和34(68%)非血液学癌症组成的患者从2005年3月至12月在尼日利亚贝宁大学教学医院接受各种治疗。通过各种特定的诊断方法估算的流变参数是在癌症患者化疗前后确定的。估计的流变学测试是通过毛细管粘度计测量的相对血浆粘度(RPV),全血粘度(WBV),红血球沉降速率(ESR)和血浆血纤蛋白原浓度(PFC)(通过英格拉姆凝块重量法估算)。与对照组相比,化疗前患者的RPV(p = 0.006)和化疗后WBV(p = 0.0231)显示出显着差异。与对照组相比,癌症患者的纤维蛋白原浓度(P <0.0001)和ESR值(P <0.0001)显着增加。结论:我们的结论是,完全降低高粘度和高纤维蛋白原性贫血可能有助于癌症患者的有效治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号